Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells

Published:2018-06-21 Issue:7 Volume:109 Page:2109-2118
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Mo Lijun¹,Zhang Xinji²,Shi Xiaojun³,Wei Lili¹,Zheng Dianpeng¹,Li Hongwei¹,Gao Jimin⁴,Li Jinlong¹,Hu Zhiming¹^ORCID

Affiliation:

1. Institute of Biotherapy; School of Laboratory Medicine and Biotechnology; Southern Medical University; Guangzhou China

2. Department of Urology; Shunde Hospital; Southern Medical University; Guangzhou China

3. Department of Urology; Nanfang Hospital; Southern Medical University; Guangzhou China

4. Zhejiang Provincial Key Laboratory of Medical Genetics; School of Life Sciences; Wenzhou Medical University; Wenzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13639/fullpdf

Reference34 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer;Obara;Can Sci,2017

3. Regulatory T cells: key controllers of immunologic self-tolerance;Sakaguchi;Cell,2000

4. Characteristics of CD4 + CD25 + regulatory T cells in the peripheral circulation of patients with head and neck cancer;Schaefer;Br J Cancer,2005

5. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma;Liyanage;J Immunol,2002

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking Immunity: Innovative prostate cancer vaccine strategies;International Immunopharmacology;2024-12

2. Chitosan-modified mesoporous silica nanoparticles for the oral delivery of Norcantharidin: In vitro and in vivo assessment;Microporous and Mesoporous Materials;2024-04

3. Dual-responsive supramolecular photodynamic nanomedicine with activatable immunomodulation for enhanced antitumor therapy;Acta Pharmaceutica Sinica B;2024-02

4. Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy;Acta Pharmaceutica Sinica B;2023-12

5. Inflammation in Prostate Cancer: Exploring the Promising Role of Phenolic Compounds as an Innovative Therapeutic Approach;Biomedicines;2023-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3